Vijay K. T. Alagappan

Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study

D. A. Mahler, Marc Decramer, Anthony D’Urzo et al. · European Respiratory Journal · 2013 · 162 citations

Medicine, Clinical Sciences, Pharmacotherapy +17

Enhanced Bronchial Expression of Extracellular Matrix Proteins in Chronic Obstructive Pulmonary Disease

Andor R. Kranenburg, Anna Willems‐Widyastuti, Wolter J. Mooi et al. · American Journal of Clinical Pathology · 2006 · 137 citations

Medicine, Cell Biology, Pathology +17

Coordinated induction of iNOS–VEGF–KDR–eNOS after resveratrol consumption

Samarjit Das, Vijay K. T. Alagappan, Debasis Bagchi et al. · Vascular Pharmacology · 2005 · 130 citations

Life Sciences, Biochemistry, Metabolic Regulation +5

Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE2SPOND): A Randomized Clinical Trial

Fernando J. Martínez, Klaus F. Rabe, Sanjay Sethi et al. · American Journal of Respiratory and Critical Care Medicine · 2016 · 125 citations

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON study

Ronald Dahl, Dalal Jadayel, Vijay K. T. Alagappan et al. · International Journal of COPD · 2013 · 73 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16